| Literature DB >> 26923309 |
Soo Yun Moon1, Sohee Kim2, Soo Young Lee3,4, Eon Chul Han3,5, Sung-Bum Kang3,4, Seung-Yong Jeong3,5,6, Kyu Joo Park3,5, Jae Hwan Oh1.
Abstract
The number of operations on elderly colorectal cancer (CRC) patients has increased with the aging of the population. The aim of this study was to evaluate surgical outcomes in elderly patients who underwent laparoscopic or open surgery for CRC. We analyzed the data of 280 patients aged 80 or over who underwent surgery for CRC between January 2001 and December 2010. Seventy-one pairs were selected after propensity score matching for laparoscopic or open surgery. Operative time, return to normal bowel function, length of hospital stay, postoperative complications, overall survival (OS), recurrence-free survival (RFS), and prognostic factors affecting survival were investigated. In matched cohorts, operative time in the laparoscopic group was longer than in the open group (P < 0.001). In the laparoscopic group, time to flatus passage (P < 0.001) and length of postoperative hospital stay (P = 0.037) were shorter than in the open group. The rate of operation-related morbidity was higher in the open group (P = 0.019). There was no difference in OS and RFS between two groups. This study suggests that laparoscopic surgery for CRC in elderly patients may be safe and feasible, with better short-term outcomes. OS and RFS, however, were not different in both groups.Entities:
Keywords: Colorectal cancer; elderly patients; laparoscopic surgery; surgical outcomes
Mesh:
Year: 2016 PMID: 26923309 PMCID: PMC4924362 DOI: 10.1002/cam4.671
Source DB: PubMed Journal: Cancer Med ISSN: 2045-7634 Impact factor: 4.452
Patient characteristics before and after matching by propensity score
| Total cohort | Matched cohort | |||||
|---|---|---|---|---|---|---|
| LAP ( | OP ( |
| LAP ( | OP ( |
| |
| Age (years) | ||||||
| Median (IQR) | 82.0 (80–84) | 82.0 (81–85) | 0.055 | 82.0 (81–84) | 82.0 (81–84) | 0.711 |
| Sex | 0.552 | 1.000 | ||||
| Male | 46 (54.1) | 98 (50.3) | 40 (56.3) | 40 (56.3) | ||
| Female | 39 (45.9) | 97 (49.7) | 31 (43.7) | 31 (43.7) | ||
| BMI (kg/m2) | ||||||
| Median (IQR) | 22.2 (20.6–24.1) | 21.6 (19.5–23.6) | 0.093 | 21.9 (20.4–24.2) | 22.0 (20.6–24.5) | 0.901 |
| ASA score | 0.882 | 0.396 | ||||
| 1 | 13 (15.3) | 35 (17.9) | 12 (16.9) | 16 (22.5) | ||
| 2 | 56 (65.9) | 120 (61.5) | 45 (63.4) | 37 (52.1) | ||
| 3 | 16 (18.8) | 38 (19.5) | 14 (19.7) | 18 (25.4) | ||
| 4 | 0 (0.0) | 2 (1.0) | ||||
| Comorbidity | 55 (64.7) | 108 (55.4) | 0.146 | 44 (62.0) | 40 (56.3) | 0.495 |
| Hypertension | 49 (57.6) | 90 (46.2) | 40 (56.3) | 34 (47.9) | ||
| Diabetes mellitus | 10 (11.8) | 26 (13.3) | 10 (14.1) | 10 (14.1) | ||
| Cardiovascular disease | 8 (9.4) | 10 (5.1) | 4 (5.6) | 3 (4.2) | ||
| Cerebrovascular disease | 4 (4.7) | 7 (3.6) | 2 (2.8) | 5 (7.0) | ||
| Pulmonary disease | 3 (3.5) | 4 (2.1) | 2 (2.8) | 0 (0.0) | ||
| TNM Stage | 0.002 | 0.978 | ||||
| I | 26 (30.6) | 25 (12.8) | 19 (26.8) | 18 (25.4) | ||
| II | 28 (32.9) | 77 (39.5) | 24 (33.8) | 24 (33.8) | ||
| III | 31 (36.5) | 93 (47.7) | 28 (39.4) | 29 (40.8) | ||
| Tumor location | 0.007 | 0.913 | ||||
| Right colon | 19 (22.4) | 61 (31.3) | 17 (23.9) | 15 (21.1) | ||
| Left colon | 44 (51.8) | 62 (31.8) | 34 (47.9) | 36 (50.7) | ||
| Rectum | 22 (25.9) | 72 (36.9) | 20 (28.2) | 20 (28.2) | ||
| Preoperative CEA (ng/mL) | 0.179 | 0.579 | ||||
| ≤5 | 59 (75.6) | 117 (67.2) | 52 (73.2) | 49 (69.0) | ||
| >5 | 19 (24.4) | 57 (32.8) | 19 (26.8) | 22 (31.0) | ||
Data are presented as n (%) unless otherwise indicated.
LAP, laparoscopic surgery; OP, open surgery; IQR, interquartile range; BMI, body mass index; ASA, American Society of Anesthesiologists; TNM, tumor node metastasis; CEA, carcinoembryonic antigen.
Perioperative outcomes in matched cohorts of laparoscopic and open surgery
| LAP ( | OP ( |
| |
|---|---|---|---|
| Type of resection | 0.385 | ||
| Right hemicolectomy | 17 (23.9) | 15 (21.1) | |
| Left hemicolectomy | 3 (4.2) | 4 (5.6) | |
| Anterior resection | 24 (33.8) | 23 (32.4) | |
| Low anterior resection | 24 (33.8) | 19 (26.8) | |
| Miles' operation | 2 (2.8) | 2 (2.8) | |
| Hartmann's operation | 1 (1.4) | 4 (5.6) | |
| Subtotal colectomy | 4 (5.6) | ||
| Operative time (min) | |||
| Median (IQR) | 182.0 (154–210) | 130.0 (80–185) | <0.001 |
| EBL (mL) | |||
| Median (IQR) | 100.0 (50–200) | 100.0 (50–300) | 0.637 |
| Harvested LN | 0.004 | ||
| <12 | 4 (5.6) | 16 (22.5) | |
| ≥12 | 67 (94.4) | 55 (77.5) | |
| Tumor grade | 0.573 | ||
| Low | 65 (91.5) | 63 (88.7) | |
| High | 6 (8.5) | 8 (11.3) | |
| Venous invasion | 19 (26.8) | 21 (29.6) | 0.709 |
| Angiolymphatic Invasion | 35 (49.3) | 20 (28.2) | 0.010 |
| Perineural invasion | 16 (22.5) | 20 (28.2) | 0.440 |
| Flatus passage (days) | |||
| Median (IQR) | 3.0 (2–4) | 4.0 (4–6) | <0.001 |
| First soft diet (days) | |||
| Median (IQR) | 5.0 (4–6) | 6.0 (5–7) | 0.004 |
| Hospital stay (days) | |||
| Median (IQR) | 9.0 (7–11) | 10.0 (8–13) | 0.037 |
Data are presented as n (%) unless otherwise indicated.
LAP, laparoscopic surgery; OP, open surgery; IQR, interquartile range; EBL, estimated blood loss; LN, lymph node.
Postoperative complications in matched cohorts of laparoscopic and open surgery
| LAP ( | OP ( |
| |
|---|---|---|---|
| Postoperative mortality | 0 (0) | 0 (0) | |
| Postoperative morbidity | 16 (22.5) | 29 (40.8) | 0.019 |
| Wound infection | 5 (7.0) | 9 (12.7) | 0.260 |
| Ileus | 3 (4.2) | 11 (15.5) | 0.024 |
| Urinary retention | 9 (12.7) | 9 (12.7) | 1.000 |
| Anastomosis leakage | 0 (0.0) | 0 (0.0) | 1.000 |
| Intra‐abdominal bleeding | 1 (1.4) | 1 (1.4) | 1.000 |
| Pneumonia | 1 (1.4) | 0 (0.0) | 1.000 |
| Other complication | 4 (5.6) | 2 (2.8) | 0.681 |
Data are presented as n (%) unless otherwise indicated.
LAP, laparoscopic surgery; OP, open surgery.
Figure 1Survival curve in matched cohorts of laparoscopic and open surgery.
Multivariable analysis for overall survival in matched cohorts of laparoscopic and open surgery
| HR | 95% CI |
| |
|---|---|---|---|
| Sex | |||
| Male | 1.00 | ||
| Female | 0.62 | 0.36–1.07 | 0.085 |
| Perineural invasion | |||
| No | 1.00 | ||
| Yes | 1.79 | 1.02–3.15 | 0.043 |
| Type of surgery | |||
| OP | 1.00 | ||
| LAP | 0.82 | 0.48–1.38 | 0.457 |
LAP, laparoscopic surgery; OP, open surgery; HR, hazard ratio; CI, confidence interval.
Multivariable analysis for recurrence‐free survival in matched cohorts of laparoscopic and open surgery
| HR | 95% CI |
| |
|---|---|---|---|
| Preoperative CEA (ng/mL) | |||
| ≤5 | 1.00 | ||
| >5 | 1.81 | 1.04–3.14 | 0.035 |
| Perineural invasion | |||
| No | 1.00 | ||
| Yes | 1.90 | 1.08–3.32 | 0.025 |
| Type of surgery | |||
| OP | 1.00 | ||
| LAP | 0.67 | 0.40–1.12 | 0.125 |
LAP, laparoscopic surgery; OP, open surgery; HR, hazard ratio; CI, confidence interval; CEA, carcinoembryonic antigen.